Reynand Wu

MacroGenics Initiates Phase I Clinical Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors macrogenics-initiates-phase-i-clinical-trial-for-novel-antibody-drug-conjugate-mgc030-in-advanced-solid-tumors-1

MacroGenics Initiates Phase I Clinical Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Reynand Wu October 17, 2026

Biopharmaceutical company MacroGenics has announced the commencement of a Phase I clinical trial for its investigational antibody-drug...

Beyond the Diagnosis: Navigating the Complex Transition to Life After Breast Cancer Treatment beyond-the-diagnosis-navigating-the-complex-transition-to-life-after-breast-cancer-treatment

Beyond the Diagnosis: Navigating the Complex Transition to Life After Breast Cancer Treatment

Reynand Wu October 17, 2026

The conclusion of active breast cancer treatment—the final infusion, the last radiation session, or the successful completion...

Radiology Reimagined: Sirona Medical Secures $40M to Fuel Global AI Transformation radiology-reimagined-sirona-medical-secures-40m-to-fuel-global-ai-transformation

Radiology Reimagined: Sirona Medical Secures $40M to Fuel Global AI Transformation

Reynand Wu October 17, 2026

In a landmark development for digital health, San Francisco-based Sirona Medical has successfully closed a $40 million...

Beyond the Stigma: Understanding and Confronting Male Breast Cancer in Canada beyond-the-stigma-understanding-and-confronting-male-breast-cancer-in-canada

Beyond the Stigma: Understanding and Confronting Male Breast Cancer in Canada

Reynand Wu October 16, 2026

To many, the diagnosis of breast cancer is inextricably linked to the female experience. It is a...

Fueling the Future: HudsonAlpha Unveils ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem fueling-the-future-hudsonalpha-unveils-the-primer-lab-to-supercharge-alabamas-biotech-ecosystem-4

Fueling the Future: HudsonAlpha Unveils ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem

Reynand Wu October 16, 2026

HUNTSVILLE, AL – In a strategic move to solidify Alabama’s position as a powerhouse in the life...

The Phoenix of Belgian Biotech: Armed Cell Therapeutics Acquires Lakefront’s CAR-T Pipeline the-phoenix-of-belgian-biotech-armed-cell-therapeutics-acquires-lakefronts-car-t-pipeline

The Phoenix of Belgian Biotech: Armed Cell Therapeutics Acquires Lakefront’s CAR-T Pipeline

Reynand Wu October 16, 2026

In a significant consolidation move within the European life sciences sector, the fledgling Belgian startup Armed Cell...

Labcorp Expands Diagnostic Footprint with $872M Acquisition of BioReference Health Assets labcorp-expands-diagnostic-footprint-with-872m-acquisition-of-bioreference-health-assets

Labcorp Expands Diagnostic Footprint with $872M Acquisition of BioReference Health Assets

Reynand Wu October 16, 2026

In a significant consolidation move within the US diagnostics sector, Labcorp has announced a definitive agreement to...

Mastering the Mat: A Comprehensive Guide to Overcoming Teaching Anxiety mastering-the-mat-a-comprehensive-guide-to-overcoming-teaching-anxiety

Mastering the Mat: A Comprehensive Guide to Overcoming Teaching Anxiety

Reynand Wu October 15, 2026

Published: October 15, 2026 For many yoga instructors, the transition from dedicated practitioner to teacher is fraught...

A Legacy of Resilience: How Richard Goldman’s Journey Defines the True Meaning of Pride a-legacy-of-resilience-how-richard-goldmans-journey-defines-the-true-meaning-of-pride-2

A Legacy of Resilience: How Richard Goldman’s Journey Defines the True Meaning of Pride

Reynand Wu October 15, 2026

Introduction: The Architecture of Community In the modern landscape of LGBTQ+ advocacy, the term "Pride" is often...

The AI Frontier: Iambic Therapeutics Hits Public Markets in $150 Million IPO the-ai-frontier-iambic-therapeutics-hits-public-markets-in-150-million-ipo

The AI Frontier: Iambic Therapeutics Hits Public Markets in $150 Million IPO

Reynand Wu October 15, 2026

The biotechnology landscape reached a significant milestone this Wednesday as Iambic Therapeutics, a standout firm in the...

MacroGenics Initiates Phase I Clinical Trial for Novel Antibody-Drug Conjugate MGC030 in Advanced Solid Tumors

Beyond the Diagnosis: Navigating the Complex Transition to Life After Breast Cancer Treatment

Radiology Reimagined: Sirona Medical Secures $40M to Fuel Global AI Transformation

Beyond the Stigma: Understanding and Confronting Male Breast Cancer in Canada

Fueling the Future: HudsonAlpha Unveils ‘The Primer Lab’ to Supercharge Alabama’s Biotech Ecosystem

The Phoenix of Belgian Biotech: Armed Cell Therapeutics Acquires Lakefront’s CAR-T Pipeline

Labcorp Expands Diagnostic Footprint with $872M Acquisition of BioReference Health Assets

Mastering the Mat: A Comprehensive Guide to Overcoming Teaching Anxiety

A Legacy of Resilience: How Richard Goldman’s Journey Defines the True Meaning of Pride

The AI Frontier: Iambic Therapeutics Hits Public Markets in $150 Million IPO

You may have missed

A New Trojan Horse: Mount Sinai Scientists Engineer CAR T-Cells to Dismantle Cancer’s Defenses, Offering Hope for Metastatic Tumors

Personalized Cancer Vaccine Shows Promise, But Data Leak Dampens Initial Enthusiasm

Empowering Action: Your Comprehensive Guide to Planning a Meaningful Breast Cancer Awareness Month

Bridging the Gap: How Taylarr Lopez is Redefining Public Health Communications for Equitable Care